Intelliject is a specialty pharmaceutical company dedicated to developing drug/device combination products that empower patients to gain freedom from their medical conditions. Each Intelliject product combines an established drug with an innovative delivery platform with the goal of achieving superiority, patient preference and cost effectiveness.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/30/12 | $15,000,000 | Venture Debt |
Hercules Technology Growth Capital | undisclosed |
